Dress syndrome associated with antituberculous drugs

Authors

  • Carlos Alberto Dávila-Hernández Universidad Nacional San Luis Gonzaga de Ica.
  • Mario Luis Franco-Soto Universidad Nacional San Luis Gonzaga de Ica.
  • María Alejandra Franco-Kuroki Universidad Nacional San Luis Gonzaga de Ica
  • Wendy Christina Castro-Parí Universidad Nacional San Luis Gonzaga de Ica

DOI:

https://doi.org/10.36393/spmi.v31i2.33

Keywords:

DRESS syndrome, hypersensitivity, eosinophilia, pulmonary tuberculosis, antituberculous drug

Abstract

A 17 years-old woman diagnosed of pulmonary tuberculosis received rifampicin, isoniazid, pyrazinamide and ethambutol. Four weeks later, she presented a skin rash, conjunctival jaundice, fever and pruritus, eosinophilia and elevated liver enzymes. With the diagnosis of DRESS syndrome, the TB treatment was stopped and corticosteroids and antihistamines were administered. The patient developed multi-organ failure and died two days after admission.

Downloads

Download data is not yet available.

Downloads

Published

2019-07-06

Issue

Section

Case report

How to Cite

Dress syndrome associated with antituberculous drugs. (2019). Revista De La Sociedad Peruana De Medicina Interna, 31(2), 60-62. https://doi.org/10.36393/spmi.v31i2.33

Most read articles by the same author(s)